Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
The AGE1.CR.pIX cell line's versatility allows it to support a wide range of viruses and vaccine types
‘Sanjeevani’ aims to raise awareness and encourage conversations around the silent cancer epidemic
The campus in Genome Valley will provide services in discovery chemistry & discovery biology, safety toxicology, bioanalytical services and formulation development to global pharmaceutical companies
National Health Authority (NHA) to host the two-day Arogya Manthan event in New Delhi
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD)
The companies will work with investigators to share the results with the scientific community
Clindamycin Phosphate Gel is used to treat acne
InvaGen has received 5 inspectional observations in Form 483
With this, the company has secured 511 marketing approvals for its oncology products across 66 countries
Subscribe To Our Newsletter & Stay Updated
